Hexin Medical key facts
as of Oct 2026- Manufacturer and developer of a magnetic levitation artificial heart designed for heart failure patients.
- Hexin Medical is valued at approximately $465.0M as of Oct 2026 (last reported valuation).
- It has raised $174.7M; the latest was IPO in Nov 2025.
- Notable investors include GL Ventures, CICC Capital, Puhua Capital, Legend Capital, Co-Stone Capital — 17 tracked in total.
- Status: In IPO Registration.
Hexin Medical's last reported valuation, Jun 2025. Nothing priced has surfaced since.
- ·The complete investor list: 17 names
- ·Watch Hexin Medical: the Monday email on marks, rounds and moves
Hexin Medical funding rounds
No funding rounds for Hexin Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Hexin Medical
17+Hexin Medical valuation
Hexin Medical's last reported valuation was $465 million in Jun 2025. No priced round, secondary trade or fund mark has surfaced since.
Hexin Medical investors
17 investors are on record for Hexin Medical, including GL Ventures, CICC Capital, Puhua Capital and Legend Capital. By type, the record holds 8 venture capital firms and 2 private equity firms.
About Hexin Medical
Manufacturer and developer of a magnetic levitation artificial heart designed for heart failure patients. The company focuses on the research and development of artificial hearts and ventricular assist medical devices, providing patients with small-size, lightweight, low-power consumption hearts.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2016
- Website
- coretechmed.com/
- Ownership
- In IPO Registration
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.